The U.S. Food and Drug Administration has approved the use of sound waves to break down tumors—a technique called histotripsy—in humans for liver treatment.
Exclusive: Column Group raises a new $400M+ fund and R&D hub for single-asset biologics companies
As the biotech industry grapples with how to fund drug development in a world of increasing research costs, rising drug prices and government-related risk, a